VentriPoint Diagnostics’s (VPT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting VentriPoint Diagnostics is a Buy.
VentriPoint Diagnostics’s (VPT) 20-Day exponential moving average is 0.07, while VentriPoint Diagnostics’s (VPT) share price is C$0.07, making it a Sell.
VentriPoint Diagnostics’s (VPT) 50-Day exponential moving average is 0.08, while VentriPoint Diagnostics’s (VPT) share price is C$0.07, making it a Sell.
VentriPoint Diagnostics’s (VPT) 10-Day exponential moving average is 0.07, while VentriPoint Diagnostics’s (VPT) share price is C$0.07, making it a Sell.
VentriPoint Diagnostics’s (VPT) 100-Day exponential moving average is 0.09, while VentriPoint Diagnostics’s (VPT) share price is C$0.07, making it a Sell.
VentriPoint Diagnostics’s (VPT) stock price is C$0.07 and VentriPoint Diagnostics’s (VPT) 50-day simple moving average is 0.08, creating a Sell signal.
VentriPoint Diagnostics’s (VPT) stock price is C$0.07 and VentriPoint Diagnostics’s (VPT) 100-day simple moving average is 0.09, creating a Sell signal.
VentriPoint Diagnostics’s (VPT) stock price is C$0.07 and VentriPoint Diagnostics’s (VPT) 200-day simple moving average is 0.11, creating a Sell signal.